Joining US, EU Probes Diabetes Drugs' Safety

Law360, New York (March 26, 2013, 6:51 PM EDT) -- Europe's top drug watchdog kicked off an investigation Tuesday into findings that diabetes drugs made by Merck & Co. Inc., AstraZeneca PLC and others may cause precancerous changes in the pancreas, weeks after U.S. regulators launched a similar probe.

The European Medicines Agency is basing the investigation on an article published in the medical journal Diabetes on Friday that suggested a class of Type 2 diabetes drug called incretin mimetics may lead to an increased risk of pancreatitis and precancerous cellular changes known as pancreatic duct...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.